Is Post-Mortem Harm Possible? Understanding Death Harm and Grief
Bioethics 2009 October; 23(8): 441-449
The purpose of this article is not to affirm or deny particular philosophical positions, but to explore the limits of intelligibility about what post-mortem harm means, especially in the light of improper post-mortem procedures at Bristol and Alder Hey hospitals in the late 1990s. The parental claims of post-mortem harm to dead children at Alder Hey Hospital are reviewed from five different philosophical perspectives, eventually settling on a crucial difference of perspective about how we understand harm to the dead. On the one hand there is the broadly 'analytical' tradition(1) of thinking that predicates the notion of harm on the basis of an existing subject. Since the dead are non-existent persons, it makes little sense to view the dead as being harmed. On the other hand, there is a phenomenological perspective, where the dead, in respect to the experience of grief, are existentially absent. This forms the basis that it is possible to harm grieving parent's experiences of how their dead are treated. The article ends with a short examination of what harming the dead implies for traditional bioethical concerns, namely, obtaining informed consent from significant others when planning medical research on the newly dead.
Permanent LinkFind in a Library
Full Text from Publisher
Children; Consent; Death; Forms; Harm; Hospitals; Informed Consent; Medical Research; Research; Philosophical Ethics; Value / Quality of Life; Informed Consent or Human Experimentation; Donation / Procurement of Organs and Tissues; Research on Special Populations; Attitudes Toward Death; Family Attitudes Toward Death; Minors / Parental Consent;
Showing items related by title, author, creator and subject.
Sudden death: ethical and legal problems of post-mortem forensic genetic testing for hereditary cardiac diseases. Elger, B S; Michaud, K; Fellmann, F; Mangin, P (2010-03)Hereditary non-structural diseases such as catecholaminergic polymorphic ventricular tachycardia (CPVT), long QT, and the Brugada syndrome as well as structural disease such as hypertrophic cardiomyopathy (HCM) and ...